Harris v. Novartis Pharmaceuticals Corporation et al
| Edith A. Harris |
| Alcon Research, LLC, Alcon Research, LTD, Novartis Pharmaceuticals Corporation, Novartis Ag, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals UK Limited and Novartis Pharma AG |
| 4:2021cv03013 |
| January 19, 2021 |
| US District Court for the District of Nebraska |
| John M Gerrard |
| Cheryl R Zwart |
| Tort Product Liability |
| 28 U.S.C. § 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 6, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 33 TEXT STRIKE ORDER that Pursuant to NEGenR 1.3(a)(4), the Motion to Dismiss for Failure to State a Claim #32 is stricken for the following reason: document filed in incorrect case. Ordered by Deputy Clerk. (LRM) |
| Filing 32 STRICKEN MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Attorney Michael K. Huffer on behalf of Defendant Novartis Pharmaceuticals Corporation.(Huffer, Michael) Modified on 3/9/2021 to add the word stricken (LRM). |
| Filing 31 BRIEF in support of MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM #30 by Attorney Michael K. Huffer on behalf of Defendant Novartis Pharmaceuticals Corporation.(Huffer, Michael) |
| Filing 30 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Attorney Michael K. Huffer on behalf of Defendant Novartis Pharmaceuticals Corporation.(Huffer, Michael) |
| Filing 29 CORPORATE DISCLOSURE STATEMENT pursuant to Fed. R. Civ. P. 7.1 identifying Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Finance Corporation, a New York Corporation, Corporate Parent Novartis Holding, AG, a Swiss Company, Corporate Parent Novartis AG, a Swiss company, whose shares are publicly traded on the Six Swiss Exchange, and whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation. by Attorney Michael K. Huffer on behalf of Defendants Novartis Pharmaceuticals Corporation, Novartis Finance Corporation, a New York Corporation, Novartis Corporation, a New York corporation, Novartis Holding, AG, a Swiss Company, Novartis AG, a Swiss company, whose shares are publicly traded on the Six Swiss Exchange, and whose American Depository Shares are publicly traded on the New York Stock Exchange.(Huffer, Michael) |
Filing 28
TEXT ORDER approving #27 Stipulation for Dismissal. Ordered by Chief Judge John M. Gerrard. (DCD)
|
| Filing 27 UNOPPOSED STIPULATION FOR DISMISSAL Without Prejudice by Attorney Michael K. Huffer on behalf of Defendants Alcon Research, LLC, Novartis Ag, Novartis Institutes for Biomedical Research, Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals UK Limited.(Huffer, Michael) |
|
Filing 26
TEXT ORDER granting #25 Motion to Extend. As to all defendants who have a March 9, 2021 answer or response deadline, the deadline for filing corporate disclosures is extended to March 9, 2021. Ordered by Magistrate Judge Cheryl R. Zwart. (Zwart, Cheryl)
|
| Filing 25 MOTION to Extend Time to File Corporate Disclosure by Attorney Michael K. Huffer on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation.(Huffer, Michael) |
| Filing 24 NOTICE of Appearance by Attorney Carter F. Thurman on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation (Thurman, Carter) |
| Filing 23 NOTICE of Appearance by Attorney Robert Johnston on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation (Johnston, Robert) |
| Filing 22 NOTICE of Appearance by Attorney Shannon N. Proctor on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation (Proctor, Shannon) |
| Filing 21 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Alcon Research, LLC. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires. (KMM) |
| Filing 20 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Novartis Institutes for Biomedical Research, Inc. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires. (KMM) |
| Filing 19 TEXT NOTICE REGARDING CORPORATE DISCLOSURE STATEMENT by Deputy Clerk as to Defendant Novartis Pharmaceuticals Corporation. Pursuant to Fed. R. Civ. P. 7.1, non-governmental corporate parties are required to file Corporate Disclosure Statements (Statements). The parties shall use the form Corporate Disclosure Statement, available on the Web site of the court at http://www.ned.uscourts.gov/forms/. If you have not filed your Statement, you must do so within 15 days of the date of this notice. If you have already filed your Statement in this case, you are reminded to file a Supplemental Statement within a reasonable time of any change in the information that the statement requires. (KMM) |
| Filing 18 TEXT ORDER granting Motion for Admission Pro Hac Vice, #17 for attorney Matthew Malinowski. Ordered by Deputy Clerk. (JLS) |
| Filing 17 MOTION for Admission Pro Hac Vice Filing fee $ 100, receipt number ANEDC-4340164 by Attorney Matthew Malinowski on behalf of Defendants Alcon Research, LLC, Novartis Ag, Novartis Institutes for Biomedical Research, Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals UK Limited.(Malinowski, Matthew) |
|
Filing 16
TEXT ORDER granting #15 Motion for Extension of Time to File a Responsive Pleading. As to all defendants, the deadline for answering or responding to Plaintiff's complaint is extended to March 9, 2021. Ordered by Magistrate Judge Cheryl R. Zwart. (Zwart, Cheryl)
|
| Filing 15 UNOPPOSED MOTION for Extension of Time to File a Responsive Pleading by Attorney Michael K. Huffer on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation.(Huffer, Michael) |
| Filing 14 NOTICE of Appearance by Attorney Kathryn J. Cheatle on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation (Cheatle, Kathryn) |
| Filing 13 NOTICE of Appearance by Attorney Ronald F. Krause on behalf of Defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., Novartis Pharmaceuticals Corporation (Krause, Ronald) |
| Filing 12 SUMMONS Returned Executed upon defendant Alcon Research, LLC on 2/11/2021. (Bogle, Brandon) |
| Filing 11 SUMMONS Returned Executed upon defendant Novartis Pharmaceuticals Corporation on 2/11/2021. (Bogle, Brandon) |
| Filing 10 Summons Issued as to defendant Novartis Pharmaceuticals Corporation. YOU MUST PRINT YOUR ISSUED SUMMONS, WHICH ARE ATTACHED TO THIS DOCUMENT. PAPER COPIES WILL NOT BE MAILED. (LRM) |
| Filing 9 Summons Requested as to Novartis Pharmaceuticals Corporation regarding Complaint #1 . (Bogle, Brandon) |
| Filing 8 Summons Returned Unexecuted as to defendant Novartis Pharmaceuticals Corporation. (Bogle, Brandon) |
| Filing 7 SUMMONS Returned Executed upon defendant Novartis Institutes for Biomedical Research, Inc. on 1/26/2021. (Bogle, Brandon) |
| Filing 6 Summons Issued as to defendants Alcon Research, LLC, Novartis Institutes for Biomedical Research, Inc., and Novartis Pharmaceuticals Corporation. YOU MUST PRINT YOUR ISSUED SUMMONS, WHICH ARE ATTACHED TO THIS DOCUMENT. PAPER COPIES WILL NOT BE MAILED. (LRM) |
| Filing 5 TEXT NOTICE OF JUDGES ASSIGNED: Chief Judge John M. Gerrard and Magistrate Judge Cheryl R. Zwart assigned. In accordance with 28 U.S.C. 636(c)(2), the parties are notified that, if all parties consent, a magistrate judge may conduct a civil action or proceeding, including a jury or nonjury trial, subject to the courts rules and policies governing the assignment of judges in civil cases. See Fed. R. Civ. P. 73; NEGenR 1.4. (LRM) |
| Filing 4 Summons Requested as to Novartis Pharmaceuticals Corporation regarding Complaint #1 . (Bogle, Brandon) |
| Filing 3 Summons Requested as to Novartis Institutes for Biomedical Research, Inc. regarding Complaint #1 . (Bogle, Brandon) |
| Filing 2 Summons Requested as to Alcon Research, LLC regarding Complaint #1 . (Bogle, Brandon) |
| Filing 1 COMPLAINT with jury demand against All Defendants ( Filing fee $ 402, receipt number ANEDC-4319787), by Attorney Brandon Bogle on behalf of Edith Harris(Bogle, Brandon) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Nebraska District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
